NishanHFernandoMD

PubMed

• 19 citations
  Multicenter, randomized, double‐blind phase 2 trial of FOLFIRI with regorafenib or placebo as second‐line therapy for metastatic colorectal cancer
  Hanna K. Sanoff, Richard M. Goldberg, Anastasia Ivanova, Seamus O'Reilly, Samer S. Kasbari, Richard D. Kim, Ray McDermott, Dominic T. Moore, William C. Zamboni, Willia...> ;Cancer. 2018 Aug 1
• Validation of wet mount microscopy against Trichomonas culture among women of reproductive age group in Western province, Sri Lanka.
  Banneheke H, Fernandopulle R, Gunasekara U, Barua A, Fernando N, Wickremasinghe R> ;Trop Biomed. 2015-06-01
• Culture and immunochromatographic technique for diagnosis of trichomoniasis.
  Banneheke H, Fernandopulle R, Prathapan S, De Silva G, Fernando N, Wickremasinghe R> ;Ceylon Med J. 2014-03-01
• Use of culture and immunochromatographic technique for diagnosis of trichomoniasis in Sri Lanka.
  Banneheke H, Fernandopulle R, Prathanapan S, de Silva G, Fernando N, Wickremasinghe R> ;Ceylon Med J. 2013-09-01
• 8 citations
  A phase II study of oxaliplatin, dose-intense capecitabine, and high-dose bevacizumab in the treatment of metastatic colorectal cancer.
  Nan Soon Wong, N. Fernando, Johanna C. Bendell, Michael A. Morse, Gerard C. Blobe, Wanda Honeycutt, Herbert Pang, Herbert Hurwitz> ;Clinical Colorectal Cancer. 2011 Sep 1
• 22 citations
  A Phase II study of Capecitabine, Oxaliplatin, Bevacizumab and Cetuximab in the Treatment of Metastatic Colorectal Cancer
  Nan Soon Wong, N. Fernando, Andrew B. Nixon, Stephanie M. Cushman, Mebea Aklilu, Johanna C. Bendell, Michael A. Morse, Gerard C. Blobe, Jill Ashton, Herbert Pang, Herb...> ;Anticancer Research. 2011 Jan 1
• 3 citations
  A Phase I Dose-Escalation Study of Imatinib Mesylate (Gleevec/STI571) plus Capecitabine (Xeloda) in Advanced Solid Tumors
  Elizabeth Dugan, Roxanne Truax, Kellen L. Meadows, Andrew B. Nixon, William P. Petros, Justin Favaro, N. Fernando, Michael A. Morse, Gerard C. Blobe, Herbert Hurwitz> ;Anticancer Research. 2010 Apr 1
• 3 citations
  Phase I dose escalation study of gemcitabine plus irinotecan in advanced solid tumors.
  Elizabeth Dugan, Roxanne Truax, Kellen L. Meadows, Gerald C. Blobe, Michael A. Morse, N. Fernando, Jon P. Gockerman, William P. Petros, Herbert Hurwitz> ;Anticancer Research. 2009 Dec 1
• 10 citations
  A Phase I study of capecitabine, carboplatin, and paclitaxel with external beam radiation therapy for esophageal carcinoma.
  Brian G. Czito, Chris R. Kelsey, Herbert Hurwitz, Christopher G. Willett, Michael A. Morse, Gerard C. Blobe, N. Fernando, Thomas A. D'Amico, David H. Harpole, Wanda Ho...> ;International Journal of Radiation Oncology, Biology, Physics. 2007 Mar 15
• Phase I dose escalation, pharmacokinetic, and biomarker study of imatinib mesylate plus capecitabine in advanced solid tumor malignancies.
  Favaro JP, Petros W, Hong T, Fernando N, Bendell JC, Gockerman JP, George DJ, Williams-Truax R, Nixon A, Yu D, Hurwitz H> ;J. Clin. Oncol.. 2006-06-20
• A phase II study of oxaliplatin (OX), capecitabine (CAP), and bevacizumab (BV) in the treatment of metastatic colorectal cancer.
  Bendell JC, Fernando N, Morse M, Blobe G, Yu D, Sutton L, Schaffer S, Honeycutt W, Franklin A, Hurwitz H> ;J. Clin. Oncol.. 2006-06-20
• 104 citations
  Increased Toxicity With Gefitinib, Capecitabine, and Radiation Therapy in Pancreatic and Rectal Cancer: Phase I Trial Results
  Brian G. Czito, Christopher G. Willett, Johanna C. Bendell, Michael A. Morse, Douglas S. Tyler, N. Fernando, Christopher R. Mantyh, Gerard C. Blobe, Wanda Honeycutt, D...> ;Journal of Clinical Oncology. 2006 Feb 1
• 8 citations
  A phase I study of eniluracil/5-FU in combination with radiation therapy for potentially resectable and/or unresectable cancer of the pancreas and distal biliary tract.
  Brian G. Czito, Timothy J. Hong, Darrel P. Cohen, William P. Petros, Douglas S. Tyler, Theodore N. Pappas, Daohai Yu, Catherine G. Lee, Albert C. Lockhart, Michael A. ...> ;Cancer Investigation. 2006 Feb 1
• Safety, tolerability and pharmacokinetics of oral administration of GW786034 in pts with solid tumors.
  Hurwitz H, Dowlati A, Savage S, Fernando N, Lasalvia S, Whitehead B, Suttle B, Collins D, Ho P, Pandite L> ;J. Clin. Oncol.. 2005-06-01
• A phase II study of oxaliplatin, capecitabine and bevacizumab in the treatment of metastatic colorectal cancer.
  Fernando N, Yu D, Morse M, Blobe G, Odogwu L, Crews J, Polito A, Honeycutt W, Franklin A, Hurwitz H> ;J. Clin. Oncol.. 2005-06-01
• 30 citations
  Successful Desensitization to Oxaliplatin
  Lydia Mis, N. Fernando, Hurbert I Hurwitz, Michael A. Morse> ;The Annals of Pharmacotherapy. 2005 May 1
• Pharmacokinetics (PK) and tolerability of GW786034, a VEGFR tyrosine kinase inhibitor, after daily oral administration to patients with solid tumors.
  Suttle AB, Hurwitz H, Dowlati A, Fernando N, Savage S, Coviello K, Dar M, Ertel P, Whitehead B, Pandite L> ;J. Clin. Oncol.. 2004-07-15
• 70 citations
  Targeted Therapy of Colorectal Cancer: Clinical Experience with Bevacizumab
  N. Fernando, Herbert Hurwitz> ;The Oncologist. 2004 Jun 1
• 65 citations
  Adjuvant external-beam radiotherapy with concurrent chemotherapy after resection of primary gallbladder carcinoma: A 23-year experience
  Brian G. Czito, Herbert Hurwitz, Robert W. Clough, Douglas S. Tyler, Michael A. Morse, Bryan M. Clary, Theodore N. Pappas, N. Fernando, Christopher G. Willett> ;International Journal of Radiation Oncology, Biology, Physics. 2003 Oct 1
• A pilot study of a low cost CLO test.
  Fernando N, Weerasekera D, Meedin F, Bogahawatta A> ;Ceylon Med J. 2003-09-01
• 88 citations
  Inhibition of vascular endothelial growth factor in the treatment of colorectal cancer
  N. Fernando, Herbert Hurwitz> ;Seminars in Oncology. 2003 Jun 1
• Theophylline blood levels in Sri Lankan asthmatics: comparison of two methods of assay.
  Goonetilleke AKE, Munasinghe TMJ, Cooray HC, Balasuriya WK, Fernando N> ;Ceylon Med J. 2002-06-01
• Biliary tract injury during cholecystectomy: a retrospective descriptive review of clinical features, treatment and outcome.
  De Silva, W. M., Sivananthan, S., De Silva, D., Fernando, N.> ;Ceylon Med J. 2006 Dec
• Join now to see all